Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Wellington Management Group LLP's stake in Apellis Pharmaceuticals, Inc. fell to 0.20% (Schedule 13G/A)
Event Mar 31, 2026 · Filed Apr 7, 2026
Wellington Management Group LLP's stake in Apellis Pharmaceuticals, Inc. fell to 0.20%, 249,635 shares, as a passive investor on Mar 31, 2026. Filed Apr 7, 2026 (Schedule 13G/A).
- Stake
- 0.20%
- Shares
- 249,635
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 0.20% | 249,635 |
| Wellington Group Holdings LLP | 0.20% | 249,635 |
| Wellington Investment Advisors Holdings LLP | 0.20% | 249,635 |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Wellington Management Group LLP
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Nov 7, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 12, 2025
- Schedule 13G/A · Wellington Management Group LLP · Feb 10, 2025
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026